Neuronetics Inc
STIM4.690USD
+0.270+6.11%
取引時間 （ET）15分遅れの株価
308.70M時価総額
損失額直近12ヶ月PER
詳細情報 Neuronetics Inc 企業名
Neuronetics, Inc. is a medical technology company focused on designing, developing, and marketing products for patients who suffer from neurohealth disorders. Its NeuroStar Advanced Therapy for Mental Health is a non-drug, noninvasive treatment for people suffering from neurohealth conditions. In addition to selling the NeuroStar system and associated treatment sessions to customers, it operates treatment centers across the United States, offering both NeuroStar Advanced Therapy (transcranial magnetic stimulation or TMS) and Spravato (esketamine nasal spray) for the treatment of major depressive disorder (MDD) and other mental health disorders. NeuroStar Advanced Therapy is the TMS treatment for MDD in adults. Spravato is offered to treat adults with treatment-resistant depression and depressive symptoms in adults with MDD with suicidal thoughts or actions. It provides more than 1.68 million treatments to over 51,000 patients struggling with depression.
企業情報
企業コードSTIM
会社名Neuronetics Inc
上場日Jun 28, 2018
最高経営責任者「CEO」Mr. Keith J. Sullivan
従業員数716
証券種類Ordinary Share
決算期末Jun 28
本社所在地3222 Phoenixville Pike
都市MALVERN
証券取引所NASDAQ Global Market Consolidated
国United States of America
郵便番号19355
電話番号18776007555
ウェブサイトhttps://neurostar.com/neuronetics/
企業コードSTIM
上場日Jun 28, 2018
最高経営責任者「CEO」Mr. Keith J. Sullivan
役員一覧
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Sasha Cucuz
Mr. Sasha Cucuz
Director
Director
2.02M
+1.50%
Mr. Keith J. Sullivan
Mr. Keith J. Sullivan
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.61M
--
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
578.24K
+6.69%
Mr. Steven Pfanstiel
Mr. Steven Pfanstiel
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
400.00K
--
Mr. Glenn P. Muir
Mr. Glenn P. Muir
Independent Director
Independent Director
327.90K
+10.07%
Ms. Sheryl L. Conley
Ms. Sheryl L. Conley
Independent Director
Independent Director
178.03K
+20.27%
Ms. Megan Rosengarten
Ms. Megan Rosengarten
Independent Director
Independent Director
140.89K
+27.05%
Mr. W. Andrew Macan
Mr. W. Andrew Macan
Executive Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
Executive Vice President, Chief Compliance Officer, General Counsel, Corporate Secretary
--
--
Dr. Avinash N. Amin, M.D.
Dr. Avinash N. Amin, M.D.
Director
Director
--
--
Mr. Mark Klausner
Mr. Mark Klausner
Managing Partner
Managing Partner
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. Sasha Cucuz
Mr. Sasha Cucuz
Director
Director
2.02M
+1.50%
Mr. Keith J. Sullivan
Mr. Keith J. Sullivan
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
1.61M
--
Mr. Robert A. (Rob) Cascella
Mr. Robert A. (Rob) Cascella
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
578.24K
+6.69%
Mr. Steven Pfanstiel
Mr. Steven Pfanstiel
Chief Financial Officer, Executive Vice President, Treasurer
Chief Financial Officer, Executive Vice President, Treasurer
400.00K
--
Mr. Glenn P. Muir
Mr. Glenn P. Muir
Independent Director
Independent Director
327.90K
+10.07%
Ms. Sheryl L. Conley
Ms. Sheryl L. Conley
Independent Director
Independent Director
178.03K
+20.27%
収益内訳
通貨: USD更新時刻: Sun, Jul 6
通貨: USD更新時刻: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
事業別USD
会社名
収益
比率
Clinic revenue
18.66M
58.35%
Treatment sessions
9.76M
30.53%
NeuroStar Advanced Therapy System
3.01M
9.41%
Other
544.00K
1.70%
地域別USD
会社名
収益
比率
United States
31.48M
98.46%
International
492.00K
1.54%
事業別
地域別
事業別USD
会社名
収益
比率
Clinic revenue
18.66M
58.35%
Treatment sessions
9.76M
30.53%
NeuroStar Advanced Therapy System
3.01M
9.41%
Other
544.00K
1.70%
株主
更新時刻: Thu, Jul 17
更新時刻: Thu, Jul 17
株主統計
種類
株主統計
株主統計
比率
Madryn Asset Management, LP
36.82%
The Vanguard Group, Inc.
3.50%
Cucuz (Sasha)
3.08%
Sullivan (Keith J)
2.44%
Balyasny Asset Management LP
2.15%
Other
52.00%
株主統計
株主統計
比率
Madryn Asset Management, LP
36.82%
The Vanguard Group, Inc.
3.50%
Cucuz (Sasha)
3.08%
Sullivan (Keith J)
2.44%
Balyasny Asset Management LP
2.15%
Other
52.00%
種類
株主統計
比率
Private Equity
36.82%
Hedge Fund
12.75%
Individual Investor
9.48%
Investment Advisor
7.53%
Investment Advisor/Hedge Fund
3.50%
Research Firm
1.84%
Pension Fund
0.09%
Bank and Trust
0.03%
Other
27.96%
機関投資家保有株
更新時刻: Tue, Jul 1
更新時刻: Tue, Jul 1
報告期間
機関投資家数
保有株式数
比率
変動額
2025Q2
183
47.01M
71.42%
-4.23M
2025Q1
191
47.19M
71.70%
-4.84M
2024Q4
155
36.70M
70.38%
+11.74M
2024Q3
153
14.58M
47.42%
-9.85M
2024Q2
159
20.22M
66.61%
-5.87M
2024Q1
183
20.38M
68.24%
-3.49M
2023Q4
191
18.37M
63.28%
-7.87M
2023Q3
201
19.69M
68.24%
-8.69M
2023Q2
222
21.10M
73.37%
-11.20M
2023Q1
226
22.33M
78.62%
-9.89M
詳細を見る
株主動向
会社名
保有株式数
比率
変動額
変動率
日付
Madryn Asset Management, LP
24.24M
36.82%
--
--
Mar 24, 2025
The Vanguard Group, Inc.
2.31M
3.5%
+1.02M
+79.97%
Mar 31, 2025
Cucuz (Sasha)
2.02M
3.08%
+30.00K
+1.50%
May 22, 2025
Sullivan (Keith J)
1.61M
2.44%
--
--
Mar 24, 2025
Balyasny Asset Management LP
1.42M
2.15%
-64.72K
-4.37%
Mar 31, 2025
Ikarian Capital LLC
1.10M
1.67%
+1.10M
--
Mar 31, 2025
Masters Capital Management, L.L.C.
1.00M
1.52%
-500.00K
-33.33%
Mar 31, 2025
Manatuck Hill Partners, LLC
920.00K
1.4%
+920.00K
--
Mar 31, 2025
Susquehanna International Group, LLP
761.91K
1.16%
+761.91K
--
Mar 31, 2025
Two Sigma Investments, LP
703.67K
1.07%
+703.67K
--
Mar 31, 2025
詳細を見る
関連ETF
更新時刻: Sat, Aug 2
更新時刻: Sat, Aug 2
銘柄名
比率
AdvisorShares Psychedelics ETF
6.11%
Invesco NASDAQ Future Gen 200 ETF
0.4%
iShares Micro-Cap ETF
0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
iShares Russell 2000 Growth ETF
0.01%
ProShares Hedge Replication ETF
0%
Proshares Ultra Russell 2000
0%
ProShares UltraPro Russell2000
0%
iShares Russell 2000 ETF
0%
Global X Russell 2000 ETF
0%
詳細を見る
AdvisorShares Psychedelics ETF
比率6.11%
Invesco NASDAQ Future Gen 200 ETF
比率0.4%
iShares Micro-Cap ETF
比率0.03%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
比率0.02%
iShares Russell 2000 Growth ETF
比率0.01%
ProShares Hedge Replication ETF
比率0%
Proshares Ultra Russell 2000
比率0%
ProShares UltraPro Russell2000
比率0%
iShares Russell 2000 ETF
比率0%
Global X Russell 2000 ETF
比率0%
配当金
過去5年間の配当金総支払額は
0.00
米ドルである。
日付
配当金
権利確定日
支払日
配当落ち日
データなし
株式分割
日付
種類
比率
データなし
日付
種類
比率
データなし
